GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » LT-Debt-to-Total-Asset

Middle East Pharmaceutical Industries Co (SAU:4016) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Middle East Pharmaceutical Industries Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Middle East Pharmaceutical Industries Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Middle East Pharmaceutical Industries Co's long-term debt to total assets ratio stayed the same from . 20 (0.00) to Sep. 2024 (0.00).


Middle East Pharmaceutical Industries Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Middle East Pharmaceutical Industries Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Middle East Pharmaceutical Industries Co LT-Debt-to-Total-Asset Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend
LT-Debt-to-Total-Asset

Middle East Pharmaceutical Industries Co Quarterly Data
Jun23 Sep23 Jun24 Sep24
LT-Debt-to-Total-Asset - - - -

Middle East Pharmaceutical Industries Co LT-Debt-to-Total-Asset Calculation

Middle East Pharmaceutical Industries Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Middle East Pharmaceutical Industries Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )/Total Assets (Q: Sep. 2024 )
=0/494.042
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Middle East Pharmaceutical Industries Co  (SAU:4016) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Middle East Pharmaceutical Industries Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Middle East Pharmaceutical Industries Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Middle East Pharmaceutical Industries Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Website
Middle East Pharmaceutical Industries Co is a holding company is engaged in manufacturing medicines, medicated and non-medicated creams and gels.

Middle East Pharmaceutical Industries Co Headlines

No Headlines